Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

1.2K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

222
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
222
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

79
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
79

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Applying Artificial Intelligence and machine learning in precision nutrition.

Nature communications·2026
Same author

A Multi-Omics Processing Pipeline (MOPP) for Extracting Taxonomic and Functional Insights from Metaribosome Profiling (metaRibo-Seq) data.

bioRxiv : the preprint server for biology·2026
Same author

Farnesoid X receptor-dependent microbiome-bile acid signaling mediates obstructive sleep apnea-induced atherosclerosis.

bioRxiv : the preprint server for biology·2026
Same author

Faecal microbiota transplant for chronic norovirus infection: a case report of donor microbiota engraftment without clinical success.

Gastroenterology report·2026
Same author

AI in Residency Application Reviews: Emerging Legal Risks.

JAMA·2026
Same author

A searchable metadata network graph for microbiome metabolomics.

bioRxiv : the preprint server for biology·2026

関連する実験動画

Updated: May 5, 2026

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
08:05

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing

Published on: March 19, 2018

19.7K

DTCの微生物群検査業界は,より多くの規制を必要としています.

Diane E Hoffmann1, Erik C von Rosenvinge2,3, Mary-Claire Roghmann3,2,4

  • 1University of Maryland School of Law, Baltimore, MD, USA.

Science (New York, N.Y.)
|March 14, 2024
PubMed
まとめ

多くの診断検査は科学的根拠が欠けていて 消費者を潜在的な害から守るため 連邦政府の監督が強化される必要があることを示しています

さらに関連する動画

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing
07:21

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Published on: August 25, 2018

12.8K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.4K

関連する実験動画

Last Updated: May 5, 2026

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
08:05

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing

Published on: March 19, 2018

19.7K
Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing
07:21

Tick Microbiome Characterization by Next-Generation 16S rRNA Amplicon Sequencing

Published on: August 25, 2018

12.8K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

3.4K

科学分野:

  • 医療診断
  • 規制科学

背景:

  • 診断検査は医療の決定に不可欠です
  • テストの正確性と信頼性を確保することが極めて重要です.

研究 の 目的:

  • 診断試験の分析的および臨床的妥当性を評価する.
  • 連邦政府の規制監督の必要性を評価する.

主な方法:

  • 診断試験の検証に関する既存の文献のレビュー
  • 診断試験に関する規制の枠組みの分析

主要な成果:

  • 多くの試験における分析的および臨床的妥当性における重大な欠陥を特定した.
  • 証拠によると,現在の監督は,消費者の害を防ぐには不十分です.

結論:

  • 診断テストは正確性を確保するために厳格な検証が必要です.
  • 連邦政府の監視が強化されれば 公衆の健康を保ち 不正な検査による害を防ぐことができます